Check Before You Invest : Asston Pharmaceuticals Ltd

Snapshot

Q.1 Which industry/sub-sector does Asston Pharmaceuticals Ltd belong to?

Asston Pharmaceuticals Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Asston Pharmaceuticals Ltd a good quality company?

Asston Pharmaceuticals Ltd is a quality company, based on a 4-year financial track record.

Q.3 Is Asston Pharmaceuticals Ltd undervalued or overvalued?

Asston Pharmaceuticals Ltd appears Overvalued, as its key valuation ratios are above with their past averages.

Q.4 Is Asston Pharmaceuticals Ltd a good buy now?

Asston Pharmaceuticals Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd revenue growth is 60.6% for FY-2025, which is above its 3-year CAGR of 37.65%, indicating faster growth.

Q.2 Return on capital employed (ROCE) of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd Return on capital employed is 42.64% for FY-2025, which is above its 3-year historical median of 37.2%. The current ROCE is above its estimated weighted average cost of capital (WACC) of 14%, indicating value creation.

Q.3 Return on Asset of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd Return on Asset is 17.89%, which is above its 3-year historical median of 9.11%, indicating improved asset utilization efficiency.

Q.4 Return on Equity (ROE) of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd Return on equity is 50.56% for FY-2025, which is in line with its 3-year historical median of 50.56%, indicating the business is making similar use of its shareholders capital.

Q.5 Cash conversion cycle of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd Cash conversion cycle is 178 days, above its 3-year historical median of 154 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	3-year Historic Median
Asset Turnover	1.04	0.92
ROE	50.56	50.56
ROCE	42.64	37.2
Cash Conversion Cycle	178 days	154 days

Q.6 Gross Profit margin of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd Gross profit margin which is the profit after deduction of direct costs, is 23.1% for FY-2025, which is in line with its 3-year median of 22.2%, indicating stable margins.

Q.7 Operating Profit Margin of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 25.54% for FY-2025, which is above its 3-year median of 23.2% indicating increasing margins.

Q.8 Net Profit Margin of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd Net Profit Margin is 17.27% for FY-2025, is above with its 3-year median of 16.16%, indicating increasing margins.

	Current Level	3-year Historic Median
Gross Profit Margin	23.1	22.2
Operating Profit Margin	25.54	23.2
Net Profit Margin	17.27	16.16

Q.9 Debt to Equity ratio of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd Debt-to-Equity ratio is 0.68, which is above with the industry average of 0.25, indicating higher debt levels in the industry.

Q.10 Debt to cash flow from operations of Asston Pharmaceuticals Ltd?

Asston Pharmaceuticals Ltd Debt to cash flow from operations is -44.55, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Asston Pharmaceuticals Ltd?

Promoters hold 50.66% of the Asston Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Asston Pharmaceuticals Ltd vs industry peers?

Asston Pharmaceuticals Ltd revenue CAGR is 37.65%, compared to the industry median CAGR of 8.24%, indicating faster growth and gaining its market share.

Profit Metrics

	Current Level	3-year Industry Median
Revenue Growth	60.6	8.2
Gross Profit Growth	209.1	11.2
Operating Profit Growth	141.6	9.8
Net Profit Growth	218.4	NAN

Operating Efficiency

	Current Level	3-year Industry Median
Asset Turnover	1.04	0.78
ROE	50.56	9.5
ROCE	42.64	11.4
Cash Conversion Cycle (days)	177.61	83

Valuation & price assessment

Q.1 Stock return of Asston Pharmaceuticals Ltd over the last decade?

Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-	-	-

Q.3 Valuation ratios of Asston Pharmaceuticals Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 3-year historical median and industry numbers?

Valuation Ratios	Current	3-year Historic Median	3-year Industry Median
Price to Earnings	15.74	16.57	33.44
Price to Book	1.78	1.89	3.09
Price to Sales	2.72	2.86	3.40
EV to EBITDA	11.17	11.70	16.10

Check more companies

5. Wockhardt

9. Pfizer

10. Neuland Laboratories

Check trending companies

1. Waaree Energies Ltd.

2. AWL Agri Business Ltd.

3. Anand Rathi Wealth Ltd.

4. Cohance Lifesciences Ltd.

5. Indraprastha Gas Ltd.